Petmed Express (NASDAQ:PETS) Lowered to “Hold” at Craig Hallum

Craig Hallum lowered shares of Petmed Express (NASDAQ:PETS) from a buy rating to a hold rating in a research note published on Friday morning, BenzingaRatingsTable reports.

Separately, BidaskClub raised shares of Petmed Express from a sell rating to a hold rating in a research report on Thursday, August 1st.

PETS traded up $0.82 on Friday, reaching $16.50. The company had a trading volume of 852,800 shares, compared to its average volume of 1,228,853. Petmed Express has a 1 year low of $15.00 and a 1 year high of $38.90. The stock has a market capitalization of $334.10 million, a PE ratio of 11.19 and a beta of 0.54. The stock has a 50-day moving average price of $16.03 and a 200-day moving average price of $19.59.

Petmed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, July 22nd. The company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.16). Petmed Express had a net margin of 11.05% and a return on equity of 23.42%. The company had revenue of $79.99 million during the quarter, compared to analysts’ expectations of $85.83 million. During the same period last year, the firm earned $0.62 earnings per share. Petmed Express’s revenue was down 8.5% on a year-over-year basis.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 9th. Shareholders of record on Friday, August 2nd were paid a $0.27 dividend. The ex-dividend date was Thursday, August 1st. This represents a $1.08 dividend on an annualized basis and a yield of 6.55%.

A number of hedge funds and other institutional investors have recently bought and sold shares of PETS. Renaissance Technologies LLC increased its stake in shares of Petmed Express by 15.6% during the second quarter. Renaissance Technologies LLC now owns 1,914,915 shares of the company’s stock worth $30,007,000 after acquiring an additional 259,100 shares during the period. Vanguard Group Inc. increased its stake in shares of Petmed Express by 11.4% during the second quarter. Vanguard Group Inc. now owns 1,407,736 shares of the company’s stock worth $22,059,000 after acquiring an additional 143,496 shares during the period. LSV Asset Management increased its stake in shares of Petmed Express by 35.0% during the first quarter. LSV Asset Management now owns 762,337 shares of the company’s stock worth $17,366,000 after acquiring an additional 197,550 shares during the period. Man Group plc increased its stake in shares of Petmed Express by 84.4% during the second quarter. Man Group plc now owns 490,754 shares of the company’s stock worth $7,690,000 after acquiring an additional 224,632 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in shares of Petmed Express by 2.9% during the second quarter. Bank of New York Mellon Corp now owns 456,011 shares of the company’s stock worth $7,146,000 after acquiring an additional 12,917 shares during the period. Institutional investors own 95.04% of the company’s stock.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Further Reading: What is Green Investing?

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.